Dagmar Stein
Pediatrics · Toledo, OHNPI 1114927977
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,524 of the $5,639 with a category attached, or 62.5%. 25 manufacturers reported payments, led by HEMA Biologics, LLC at 46.5% of the total. Reporting peaked in 2022 at $3,761 and has fallen 89.3% since, to $404 in 2025. Among pediatrics clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 84 payments — averaging $67.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- HEMA Biologics, LLC$3K
- Bayer$1K
- Sanofi$223
- Pfizer$183
- Shire North American Group Inc$170
- Amgen$166
- plus $1K from 19 others
What the payments were for
- Consulting fees$3,52462%
- Food & beverage$2,06037%
- Education$551%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| HEMA Biologics, LLC | 7 | $2,624 |
| Bayer | 3 | $1,064 |
| Sanofi | 9 | $223 |
| Pfizer | 9 | $183 |
| Shire North American Group Inc | 4 | $170 |
| Amgen | 3 | $166 |
| CSL Behring | 6 | $158 |
| Novo Nordisk | 7 | $124 |
| Genentech USA, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $99 |
| Bioverativ Therapeutics Inc. | 1 | $94 |
| Medexus Pharma, Inc. | 2 | $89 |
| Chiesi USA, Inc. | 1 | $81 |
| Emmaus Medical, Inc. | 4 | $76 |
| Biomarin Pharmaceutical Inc. | 4 | $76 |
| Genentech, Inc. | 3 | $60 |
| Grifols USA, LLC | 3 | $51 |
| Agios Pharmaceuticals, Inc. | 2 | $50 |
| Kedrion Biopharma Inc. | 2 | $34 |
| Adaptive Biotechnologies Corporation | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $18 |
| Kedrion Biopharma, Inc. | 1 | $16 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,639 in reported general payments places this provider in the 95th percentile of 2,041 pediatrics providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NeupogenFilgrastim | 11 | $94,531 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenNeupogen | $166 | $94,53111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,041 pediatrics providers in Ohio.
Other pediatrics in Toledo
- Lisa RichardsToledo$31K
- Diane NieseToledo$5K
- Mark WatkinsToledo$4K
- Jon DvorakPerrysburg$212K
- Charles DebrosseCincinnati$135K
- Scott WexelblattCincinnati$64K
- Breanne RocheSolon$58K
- Richard BreenHilliard$43K
- Catherine McDanielDayton$34K
- Kristie RossCleveland$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.